Biocon has announced a board meeting scheduled for November 11, 2025, to review and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025 (Q2). The trading window for dealing in the company’s securities is currently closed and will reopen on November 14, 2025.
Board Meeting for Financial Results
A meeting of the Board of Directors at Biocon is scheduled for November 11, 2025. The primary agenda is to approve and record the company’s unaudited standalone and consolidated financial results.
Financial Period Covered
The financial results under review are for the quarter and half-year period that concluded on September 30, 2025. This corresponds to the company’s performance during the second quarter (Q2) of the financial year.
Trading Window Closure
The trading window, which restricts company insiders from trading in Biocon’s securities, is currently closed. It has been closed from October 01, 2025, and will remain so through November 13, 2025. The trading window will reopen on November 14, 2025.
Source: BSE
